Related by context. Frequent words. (Click for all words.) 68 plus prednisone 68 metastatic hormone refractory 67 refractory chronic lymphocytic 67 advanced carcinoid 66 relapsed refractory multiple myeloma 66 HER2 positive metastatic breast 66 metastatic castration resistant 66 plus OBT 65 BY ADRIAN NEMES 65 metastatic castrate resistant 65 unresectable 64 refractory multiple myeloma 64 plus gemcitabine 64 YOUR LOCAL ANIMAL SHELTER 63 Chronic Hepatitis C 63 recurrent glioblastoma multiforme 63 plus dexamethasone 62 heavily pretreated 62 Metastatic Colorectal Cancer 62 R sorafenib tablets 62 By Arek Sarkissian 62 relapsed multiple myeloma 62 castrate resistant prostate cancer 62 metastatic renal cell carcinoma 61 Meets Primary Endpoint 61 Acute Myeloid Leukemia AML 61 sunitinib malate 61 EGFR expressing mCRC 61 Initiates Phase II 60 diagnosed GBM 60 carboplatin paclitaxel 60 IV metastatic melanoma 60 Completes Enrollment 60 platinum refractory 60 FOLFOX4 60 Initiate Phase 60 II Clinical Trial 60 diagnosed multiple myeloma 60 lymphoma CTCL 60 forodesine 60 multicenter Phase 60 Cell Lung Cancer 60 #mg/m# [002] 60 FOLFIRI 59 Metastatic Breast Cancer 59 ThermoDox R 59 Ixempra 59 POGO ™ 59 5-FU/LV 59 histologically confirmed 59 Regulatory Disclosure 59 KRAS wild 59 Improves Survival 59 Gemzar ® 59 Relapsed 59 primary hypercholesterolemia 59 mRCC 59 CIMZIA TM 59 Receives Orphan Drug Designation 59 Cloretazine R VNP#M 59 Metastatic Melanoma 59 BY DOUGLAS HANKS 59 Daclizumab 59 Initiates Phase 59 relapsing multiple sclerosis 59 Pegasys ® 59 Phase Ib II 59 follicular non 59 J Am Acad 58 nab paclitaxel 58 DOXIL 58 By Neil Osterweil 58 metastatic squamous cell carcinoma 58 registrational trial 58 Patients Treated 58 IV melanoma 58 pertuzumab 58 NYHA Class II 58 Marcus Gronholm BP 58 diagnosed Ph + 58 Epratuzumab 58 TORISEL 58 leukemia CLL 58 phase Ib 58 #mg/m# [001] 58 Chronic Lymphocytic Leukemia 58 FOLFOX 58 HGS ETR1 58 metastatic RCC 58 docetaxel chemotherapy 58 advanced NSCLC 58 neoadjuvant chemotherapy 58 Pivotal Phase 57 Advanced Prostate Cancer 57 Amrubicin 57 refractory peripheral T 57 dose escalation trial 57 vandetanib 57 phase IIb clinical 57 IIa trial 57 non squamous